Texas H&S §481.117 Possession of Controlled Substance Penalty Group 3

Statutory elements — § 481.117(a)

Texas Health & Safety Code § 481.117(a) provides that, except as authorized by Chapter 481, a person commits an offense if the person knowingly or intentionally possesses a controlled substance listed in Penalty Group 3, unless the person obtained the substance directly from or under a valid prescription or order of a practitioner acting in the course of professional practice.

"Knowingly or intentionally" mens rea. Penal Code § 6.03(a)-(b) governs. The defendant must intend the possession or know the substance is in their possession; identification of the specific substance is not required, but knowledge that the substance is a controlled substance is.

"Possesses." Penal Code § 1.07(a)(39) covers actual and constructive possession. The "affirmative links" framework applies; PG 3 cases frequently involve household pill bottles, vehicle compartments, and shared spaces with constructive-possession theories.

The prescription exception — the defining feature of PG 3. The statute excludes substances "obtained directly from or under a valid prescription or order of a practitioner acting in the course of professional practice." Most PG 3 substances are routinely prescribed medications. The prescription exception applies when the defendant has a valid prescription for the specific substance in their possession; it does not apply to substances obtained from another person's prescription, substances obtained from internet pharmacies operating outside lawful authority, or substances in quantities exceeding the prescribed amount.

Penalty Group 3 substances under § 481.104. The schedule includes benzodiazepines (alprazolam, diazepam, clonazepam, lorazepam, temazepam, and others); barbiturates including phenobarbital and certain others; certain stimulants including some ADHD medications in specific dosage configurations; lower-dose codeine combination products; certain anti-anxiety and sedative medications; and a substantial list of additional substances enumerated by chemical name or brand name.

Adulterants and dilutants. § 481.002(5) aggregation applies. Pills counted at full pill weight; liquids counted at total liquid weight; tinctures and syrups counted at total formulation weight.

What is in Penalty Group 3

Penalty Group 3 under § 481.104 is concentrated on legitimate prescription substances that have abuse potential. The list is dominated by benzodiazepines, barbiturates, lower-dose opioid combinations, and certain stimulants.

Benzodiazepines. The largest category by prosecution volume. Alprazolam (Xanax), diazepam (Valium), clonazepam (Klonopin), lorazepam (Ativan), temazepam (Restoril), and a substantial number of additional benzodiazepine compounds. Both brand-name and generic formulations are scheduled identically.

Barbiturates. Phenobarbital, butalbital (often in combination products like Fioricet), and other barbiturate compounds. Barbiturate prosecutions are less common than benzodiazepine prosecutions because barbiturates are less frequently prescribed than they once were.

Lower-dose codeine products. Combination products containing codeine in lower doses (typically less than 1.8 grams of codeine per 100 milliliters of preparation) fall in PG 3. Higher-dose preparations fall in PG 1. The dose-and-formulation analysis matters: a defendant in possession of "codeine syrup" can be in PG 3 or PG 1 depending on the specific formulation.

ADHD stimulants in certain configurations. Some stimulant medications fall in PG 3 under specific dosage or formulation configurations. The schedule classification for any specific ADHD prescription medication should be verified against the current statute — schedules have changed over time.

Anabolic steroids. Anabolic steroids fall in Penalty Group 3 in Texas, though federally they are Schedule III. Anabolic-steroid possession cases (gym and fitness contexts) are prosecutable under § 481.117.

Various depressants and minor stimulants. The schedule includes a long list of additional substances scheduled by chemical name.

Compared to Penalty Group 4. § 481.105 (PG 4) covers compounds with even lower abuse potential — certain opioid-acetaminophen combinations in very low doses, certain depressants. PG 4 possession is prosecuted under § 481.118 with similar but somewhat lower penalty structure.

Weight tiers — the misdemeanor threshold

The structural feature that defines § 481.117 prosecutions is the misdemeanor threshold for low-quantity possession. § 481.117(b)-(e) sets four weight tiers:

§ 481.117(b) — Less than 28 grams. Class A misdemeanor. Punishment under Penal Code § 12.21: up to one year in county jail plus a fine up to $4,000. This is the defining feature of PG 3 — quantities that would be state jail felonies under PG 1 or PG 2 are misdemeanors here. Probation is available up to two years; deferred adjudication is available.

§ 481.117(c) — 28 grams or more but less than 200 grams. Third-degree felony under § 12.34. Punishment range: 2 to 10 years TDCJ plus a fine up to $10,000.

§ 481.117(d) — 200 grams or more but less than 400 grams. Second-degree felony under § 12.33. Punishment range: 2 to 20 years TDCJ plus a fine up to $10,000.

§ 481.117(e) — 400 grams or more. First-degree felony. Punishment range: 5 to 99 years or life TDCJ plus a fine up to $50,000.

Pill counts and aggregate weight. The 28-gram misdemeanor threshold is generous in pill terms. A typical 1-milligram Xanax pill weighs roughly 100-200 milligrams including binders and coatings. A 28-gram quantity represents roughly 150-280 individual Xanax pills, depending on dosage and formulation. Most user-level possession cases fall well under the misdemeanor threshold; prosecutions in the third-degree-and-up range typically involve substantial pill counts or large liquid-formulation volumes.

Drug-free zone enhancement. § 481.134 zone enhancement applies to § 481.117 offenses. A misdemeanor under § 481.117(b) committed in a drug-free zone is enhanced to a state jail felony — eliminating the misdemeanor advantage for cases in covered locations.

Why the misdemeanor floor matters for charging strategy. The misdemeanor floor changes the entire prosecution dynamic. Pretrial intervention is broadly available; deferred adjudication is routinely granted; criminal-record consequences are substantially lighter than felony cases. Defense counsel selected at the outset can often produce dispositions that preserve the defendant's record entirely.

The prescription-status question — and where it goes wrong

Most PG 3 cases turn on whether the defendant had a valid prescription for the substance. The prescription analysis has several recurring failure modes that produce prosecutions.

The valid prescription standard. The defense applies when the defendant obtained the substance "directly from or under a valid prescription or order of a practitioner acting in the course of professional practice." Three elements: (1) a valid prescription; (2) for this defendant; (3) from a practitioner acting within professional scope.

Wrong-bottle, wrong-name cases. A defendant in possession of pills outside their original prescription bottle — in a pill organizer, in a friend's purse, in a vehicle compartment — faces a possession charge that the prescription does not automatically defeat. Defense counsel needs to document the chain: the legitimate prescription, the legitimate dispensation, and the legitimate continuing possession at the time of the arrest. Pharmacy records, prescription bottles, and physician statements all matter.

Someone else's prescription. Possession of a substance prescribed to another person — a family member, a spouse, a roommate — is not within the prescription exception. The exception applies to the prescription holder, not to anyone else with access. "I was holding it for my mother" is not a defense.

Internet pharmacy and out-of-country prescriptions. Substances obtained from internet pharmacies operating outside lawful authority, from foreign pharmacies without a U.S. prescription, or under telehealth arrangements that do not satisfy the "professional practice" requirement may not qualify. The defense analysis is fact-specific; counsel should examine the specific pharmacy and prescriber documentation.

Excess-of-prescription quantities. Possession of substantially more than the prescribed amount can support a charging theory of unlawful possession or accumulation. Defense counsel should reconcile the actual possessed quantity against the prescription dosage and the legitimate refill history.

Expired prescriptions. An old prescription that has lapsed under medical-practice rules creates a borderline case. The substance may have been lawfully obtained originally but no longer be under a current valid prescription. The defense is sometimes contestable but is meaningfully harder than for a current prescription.

"Doctor shopping" cases. § 481.129 makes it an offense to obtain a controlled substance through fraud, misrepresentation, or concealment, including by failing to disclose other current prescriptions or by visiting multiple prescribers without disclosure. Doctor-shopping prosecutions are independent of pure possession and often carry separate charges.

How these cases actually arise

Texas § 481.117 prosecutions follow several recognizable patterns. Each presents distinct defense issues.

Traffic stops with pills in transit. The most common pattern. An officer initiates a stop and discovers pills loose in the vehicle (in a pill organizer, in a baggie, in an unlabeled container). Defense priorities: prescription verification, suppression of the stop and search, possession theory (if pills were in a shared vehicle).

Search-warrant executions. Pills discovered during residential search warrants for other offenses or for the substance itself. Cases often involve combinations of PG 3 substances, alcohol-related items, and other paraphernalia. The defense template depends on the underlying warrant predicate and the substance-by-substance possession analysis.

Recovery community and treatment-program contexts. Defendants in recovery programs (substance abuse treatment, intensive outpatient programs, sober living) sometimes face § 481.117 prosecutions when relapse produces pill possession. These cases frequently present substantial mitigation profiles and qualify for diversion or treatment-track dispositions.

School and workplace possession. Pills discovered in backpacks, lockers, or workplace lockers. School-based cases often invoke the drug-free zone enhancement (eliminating the misdemeanor advantage). Workplace cases often produce parallel employment consequences.

Healthcare-worker diversion cases. Nurses, pharmacists, doctors, and other healthcare workers who divert controlled substances from their workplace face § 481.117 prosecutions plus parallel licensing board investigations. The criminal case and the licensing case must be coordinated.

Elder care and family caregiver cases. Adult children handling medications for aging parents sometimes face prosecution when found in possession of the parent's prescriptions. The "directly from or under a valid prescription" language does not categorically protect family caregivers; counsel should examine the specific role and documentation.

Online purchase and shipping interception cases. Less common with PG 3 than with PG 1 or PG 2 but still real. Pills purchased through dark-web or grey-market online pharmacies and intercepted in mail produce both possession and sometimes federal exposure under the Federal Controlled Substances Act.

Pharmacy theft and burglary cases. Defendants charged with pharmacy burglary or theft face PG 3 possession charges in addition to property crime charges. Combined exposure is substantial.

Defense strategy — prescription, possession, suppression

The defense template for § 481.117 cases has a recognizable shape, with prescription verification as the dominant first lever.

Prescription verification. The first defense investigation. Pharmacy records, physician statements, treatment-plan documentation, and original prescription bottles establish the prescription chain. Even when the substance was outside the original bottle at the time of arrest, a documented prescription substantially affects the prosecutorial discretion and the charging configuration. Counsel should obtain the pharmacy print-out of the defendant's prescription history early.

Fourth Amendment suppression. Same framework as other drug cases. Traffic-stop scope, search-warrant probable cause, consent voluntariness, K-9 alert reliability, and exit-of-stop questioning all support suppression motions. PG 3 cases that depend on pill discovery during the stop often have meaningful suppression posture.

Possession element. Standard affirmative-links analysis. Pills in shared vehicles, jointly occupied residences, or commonly accessible storage produce constructive-possession issues. Counsel should map the affirmative links the state intends to rely on and contest each.

Substance identification. Pills are typically identifiable visually by markings, color, and shape — but visual identification is not conclusive. Lab testing confirms the substance. Counterfeit pills designed to look like prescription substances (counterfeit Xanax or Adderall containing actual fentanyl or methamphetamine) have introduced a new dimension — the substance the defendant believed they possessed may not be the substance actually possessed. The mens rea analysis becomes interesting in counterfeit cases.

Charging-level negotiation. Where the substance is confirmed and the possession is established, the operative defense question is often the charging level. Aggregation challenges can sometimes move a third-degree case down to misdemeanor (under 28 grams). Mixture-vs-pure analysis matters with liquid formulations.

Diversion track. Most Texas counties make first-offense user-quantity PG 3 cases eligible for pretrial diversion or specialized Drug Court. Misdemeanor cases under § 481.117(b) are particularly diversion-friendly. Successful completion produces dismissal and preserves the defendant's record.

Licensing-board coordination. Healthcare-worker cases require parallel coordination with the relevant licensing board. The criminal-case posture affects the licensing case and vice versa; settlement of one without coordination with the other frequently produces adverse outcomes.

First 30 days — what to do, in order

Days 1–3. Retain counsel before any further interview. PG 3 cases frequently produce voluntary post-arrest statements from defendants who believe their prescription history will resolve the case — and those statements are recorded and discoverable. Counsel arranges pretrial release and instructs the defendant on no-statement obligations. The prescription investigation begins immediately; the defendant authorizes pharmacy and physician record releases under HIPAA waivers.

Days 3–10. Counsel obtains the pharmacy prescription history, physician records (current and historical) for any relevant prescribing physician, and any treatment-program documentation that supports the legitimate-medical-use posture. Preservation letters issue to law enforcement for body camera, dashcam, and any vehicle-search documentation.

Days 10–20. Counsel requests the offense report, the lab analysis report, and any search-warrant documentation. The substance identification and weight measurement are reviewed against the charging level. Defense priorities are sequenced: prescription verification first (often resolves the case entirely or substantially); suppression second; possession theory third; charging-level negotiation fourth.

Days 20–30. Counsel opens dialogue with the prosecutor on charging configuration, diversion eligibility, and plea posture. For documented-prescription cases, the operative ask is dismissal or pretrial intervention. For non-prescription cases, the diversion-track or misdemeanor-charging-level negotiation is the dominant posture. For healthcare-worker and other licensure-affected cases, counsel coordinates with licensing counsel on the parallel proceeding.

The PG 3 timeline is somewhat more forgiving than PG 1 or PG 2 timelines because of the misdemeanor floor and the broader diversion availability. But the same investigation principles apply — counsel selected on day three has substantially more to work with than counsel selected on day ninety.